JXR executes fresh HKD 2.96 million share buyback; outstanding repurchases now 70.41 million shares

Bulletin Express05-15

Jinxin Fertility Group Limited (JXR) disclosed that it repurchased 1.24 million ordinary shares on 15 May 2026 via on-market transactions at a uniform price of HKD 2.38 per share, for a total consideration of HKD 2.96 million.

The latest transaction lifts the cumulative number of shares bought back under the current mandate, granted on 26 June 2025, to 70.41 million—equivalent to 2.57 % of the company’s issued share capital on the mandate date.

As at the close of 15 May 2026, JXR’s issued share capital remains at 2.71 billion shares. Of these, 30.75 million shares (1.14 % of the current issued base) have been repurchased but are still pending formal cancellation.

The repurchase window triggers a 30-day moratorium on new share issues, sales, or transfers, restricting such activities until 14 June 2026, in line with Hong Kong listing rules. All repurchases were conducted in accordance with the Main Board regulations, and the company reports no changes to the explanatory statement filed on 4 June 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1136201923?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 20:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136201923","market":"us","top_or_hot":-1,"title":"JXR executes fresh HKD 2.96 million share buyback; outstanding repurchases now 70.41 million shares","media":"Bulletin Express","content":"<p>Jinxin Fertility Group Limited (JXR) disclosed that it repurchased 1.24 million ordinary shares on 15 May 2026 via on-market transactions at a uniform price of HKD 2.38 per share, for a total consideration of HKD 2.96 million.</p>\n<p>The latest transaction lifts the cumulative number of shares bought back under the current mandate, granted on 26 June 2025, to 70.41 million—equivalent to 2.57 % of the company’s issued share capital on the mandate date.</p>\n<p>As at the close of 15 May 2026, JXR’s issued share capital remains at 2.71 billion shares. Of these, 30.75 million shares (1.14 % of the current issued base) have been repurchased but are still pending formal cancellation.</p>\n<p>The repurchase window triggers a 30-day moratorium on new share issues, sales, or transfers, restricting such activities until 14 June 2026, in line with Hong Kong listing rules. All repurchases were conducted in accordance with the Main Board regulations, and the company reports no changes to the explanatory statement filed on 4 June 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JXR executes fresh HKD 2.96 million share buyback; outstanding repurchases now 70.41 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJXR executes fresh HKD 2.96 million share buyback; outstanding repurchases now 70.41 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-15 20:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jinxin Fertility Group Limited (JXR) disclosed that it repurchased 1.24 million ordinary shares on 15 May 2026 via on-market transactions at a uniform price of HKD 2.38 per share, for a total consideration of HKD 2.96 million.</p>\n<p>The latest transaction lifts the cumulative number of shares bought back under the current mandate, granted on 26 June 2025, to 70.41 million—equivalent to 2.57 % of the company’s issued share capital on the mandate date.</p>\n<p>As at the close of 15 May 2026, JXR’s issued share capital remains at 2.71 billion shares. Of these, 30.75 million shares (1.14 % of the current issued base) have been repurchased but are still pending formal cancellation.</p>\n<p>The repurchase window triggers a 30-day moratorium on new share issues, sales, or transfers, restricting such activities until 14 June 2026, in line with Hong Kong listing rules. All repurchases were conducted in accordance with the Main Board regulations, and the company reports no changes to the explanatory statement filed on 4 June 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01951","symbol_name":"锦欣生殖","start_time":0,"source_url":"","article_id":"1136201923","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136201923","pubTimestamp":1778847803,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jinxin Fertility Group Limited (JXR) disclosed that it repurchased 1.24 million ordinary shares on 15 May 2026 via on-market transactions at a uniform price of HKD 2.38 per share, for a total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01951":"锦欣生殖"},"translate_title":"JXR执行新的296万港元股票回购；目前未完成回购7041万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01951":1},"content_text":"Jinxin Fertility Group Limited (JXR) disclosed that it repurchased 1.24 million ordinary shares on 15 May 2026 via on-market transactions at a uniform price of HKD 2.38 per share, for a total consideration of HKD 2.96 million.\nThe latest transaction lifts the cumulative number of shares bought back under the current mandate, granted on 26 June 2025, to 70.41 million—equivalent to 2.57 % of the company’s issued share capital on the mandate date.\nAs at the close of 15 May 2026, JXR’s issued share capital remains at 2.71 billion shares. Of these, 30.75 million shares (1.14 % of the current issued base) have been repurchased but are still pending formal cancellation.\nThe repurchase window triggers a 30-day moratorium on new share issues, sales, or transfers, restricting such activities until 14 June 2026, in line with Hong Kong listing rules. All repurchases were conducted in accordance with the Main Board regulations, and the company reports no changes to the explanatory statement filed on 4 June 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1136201923","isCrawlerRequest":true}